TELA Bio (TELA) Interest Coverage Ratio Growth (1y) (2019 - 2026)
TELA Bio (TELA) Interest Coverage Ratio Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.90 Bn | 176.61 Bn | 6.27 Bn | -45.18% |
| 2 | Stryker | 128.85 Bn | 125.97 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 108.77 Bn | 99.55 Bn | 6.41 Bn | 59.82% |
| 4 | Boston Scientific | 68.39 Bn | 66.93 Bn | 3.61 Bn | -80.85% |
| 5 | Edwards Lifesciences | 48.50 Bn | 44.83 Bn | 1.29 Bn | 11.06% |
| 6 | GE HealthCare Technologies | 28.36 Bn | 26.08 Bn | 1.98 Bn | -6.18% |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | 189.50% |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.48 Bn | 22.35 Bn | 2.07 Bn | -54.61% |
| 10 | TELA Bio | 38.24 Mn | -1.30 Mn | 12.52 Mn | 34.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.43% |
| Dec 31, 2025 | -182.73% |
| Sep 30, 2025 | 9.73% |
| Jun 30, 2025 | 12.94% |
| Mar 31, 2025 | -110.97% |
| Dec 31, 2024 | 71.82% |
| Sep 30, 2024 | 8.70% |
| Jun 30, 2024 | -67.78% |
| Mar 31, 2024 | 59.89% |
| Dec 31, 2023 | 58.68% |
| Sep 30, 2023 | 3.46% |
| Jun 30, 2023 | 52.73% |
| Mar 31, 2023 | -22.12% |
| Dec 31, 2022 | -382.56% |
| Sep 30, 2022 | -349.13% |
| Jun 30, 2022 | -1,009.38% |
| Mar 31, 2022 | -105.32% |
| Dec 31, 2021 | -72.56% |
| Sep 30, 2021 | 40.32% |
| Jun 30, 2021 | 52.65% |